Recent News

• 12.23.2025 - Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
• 12.22.2025 - World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
• 12.19.2025 - World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
• 12.01.2025 - Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
• 11.28.2025 - REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC

Recent Filings

• 12.23.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.23.2025 - EX-99.1 EX-99.1
• 12.22.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 12.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.22.2025 - EX-99.1 EX-99.1
• 12.22.2025 - EX-99.1 EX-99.1
• 12.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.22.2025 - EX-99.1 EX-99.1
• 12.11.2025 - 6-K/A Report of foreign issuer [Rules 13a-16 and 15d-16]